🇺🇸 FDA
Patent

US 9180179

Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host

granted A61KA61K2039/5252A61K2039/5254

Quick answer

US patent 9180179 (Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5252, A61K2039/5254, A61K2039/552, A61K2039/55566